arrow
K

Kristine Færch

Aalborg University
H指数:45
被引数:6,661

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of exercise and exercise timing on energy intake and appetite control: a randomised crossover trial in people with overweight or obesity with and without type 2 diabetes

运动及运动时间对能量摄入和食欲控制的影响:一项针对有和无2型糖尿病的超重或肥胖人群的随机交叉试验

2026-07-010
OA
Effects of time-restricted eating on glycemic control and variability in individuals with overweight/obesity and prediabetes: A secondary analysis of the RESET randomized controlled trial

限时进食对超重/肥胖和糖尿病前期个体血糖控制和变异性的影响:RESET随机对照试验的二次分析

2026-04-210
PRE
Process Evaluation of a Time-Restricted Eating Intervention for Weight Management in South African Women Living with Overweight/Obesity and HIV on Dolutegravir-Based Antiretroviral Therapy: A Qualitative, RE-AIM-Informed Analysis

基于dolutegavir的抗逆转录病毒疗法对超重/肥胖和HIV的南非妇女进行体重管理的时间限制饮食干预的过程评估: 定性,重新瞄准的分析

2026-02-010
OAAI
Theory-based process evaluation of a non-randomised single-arm pilot study investigating time-restricted eating in the treatment of type 2 diabetes-the RESET2 pilot study

基于理论的过程评估:一项关于在2型糖尿病治疗中探究限时进食的非随机单臂试点研究——RESET2试点研究

2025-11-060
OA
What are the most important research questions within prediabetes? A priority setting partnership in collaboration with patients, healthcare professionals and researchers

在糖尿病前期研究中,最重要的研究问题是什么?一项与患者、医疗保健专业人员和研究人员合作开展的重点设置合作研究。

2025-08-040
OAAI
Protocol for a 1-year randomised, controlled, parallel group, open-label trial on the effects and feasibility of time-restricted eating in individuals with type 2 diabetes- The Restricted Eating Time in the Treatment of Type 2 Diabetes (RESET2) trial
2025-01-110
OA
The Effectiveness of Digital Health Lifestyle Interventions on Weight Loss in People With Prediabetes: A Systematic Review, Meta-Analysis, and Meta-Regression

数字健康生活方式干预对糖尿病前期患者减肥的有效性: 系统评价,荟萃分析和荟萃回归

2024-11-071
PRE
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel , superiority, open-label, randomised controlled trial
2024-05-014
OA